The Physiological Chronobiome Modified by Age, Sex and Under Evoked Conditions

NCT ID: NCT04225442

Last Updated: 2025-11-05

Basic Information

• Recruitment Status: ACTIVE_NOT_RECRUITING
• Clinical Phase: NA
• Total Enrollment: 48 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2020-01-05
• Study Completion Date: 2027-06-04

Brief Summary

The investigators piloted the characterization of the human chronobiome. Now, this line of research is extended to explore physiological chronobiome modulated by sex, age and under evoked conditions.

Detailed Description

"Is your body clock important? Absolutely. Just ask any morning lark who lives with a night owl, or vice versa". This quote from a piece published in the Philadelphia Inquirer about the investigator's work illustrates the importance of time in one's personal preferences [https://www.inquirer.com/health/chronobiome-body-clock-university-pennsylvania-20190307.html].

Several decades of research have found out that how well a person functions, very much depends on how much this person is in harmony with her/his own preferences and environment. This harmony is acutely disturbed when one travels quickly across several time zones, because suddenly the body's physiology is still following the departure time but the arrival time tells the body something different. As a result, travelers often experience sleep problems and indigestion, which usually disappear after a couple of days. This is different in long-term shift workers for whom work outside of the typical daylight hours means that they have a higher risk for diseases including cardiovascular diseases, diabetes and cancer.

Another observation has been that many diseases occur or worsen at a specific time of day. Heart attacks, for example, most often occur when patients wake up in the morning. Shortness of breath peaks at 4 am in the morning for patients with asthma.

Intriguingly, more and more studies suggest that time of day matters how effective drugs work and how many side effects one might experience. To study this the investigators started to describe the human chronobiome, which foremost looks at time of day differences of a person's physiology, for example, in the small pilot study the investigators saw a difference in break down products, or metabolites, between mornings and evenings. Now, in this present study, the investigators wish to extend the understanding how the human chronobiome differs between healthy men and women, healthy young and old and how it reacts to a fatty meal challenge.

This knowledge will help the investigators to say when a finding can still be considered normal or maybe indicates a first sign of disease. The novelty of this approach is that the investigators measure long enough to understand the role of time of day for a person's chronobiome, that the investigators measure many things to obtain a comprehensive representation of a person's chronobiome, that every measure is timestamped, and that the investigators ask participants to eat fatty meals to see how the chronobiome changes.

Conditions

Healthy; Healthy Aging

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: OTHER
• Blinding Strategy: NONE

Study Groups

Fatty meal

To study how a fatty meal modifies the physiological chronobiome in young and old, an isocaloric controlled liquid high fat meal (ICLHFM) will be consumed within 5 min. The ICLHFM contains an equivalent to 35% of the estimated total daily energy requirements (TDE), 60% of kcal delivered from fat while 13% come from protein and 27 % from carbohydrate.

Group Type: OTHER

Fatty meal to challenge the physiological chronobiome in healthy young and old

Intervention Type: OTHER

The intervention consists of a fatty meal

Interventions

Fatty meal to challenge the physiological chronobiome in healthy young and old

The intervention consists of a fatty meal

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

1. Young: 18-30 years of age, Old: 55-75 years of age

2. Apparent healthy

3. BMI (body mass index) up to 27.4

4. Upper arm with intact skin, i.e. without areas of breached or injured skin visible, for ambulatory blood pressure (ABP) measurements,

5. Own and use a smartphone.

Exclusion Criteria

1. History of severe psychiatric illness or cognitive conditions, for example (mania, schizophrenia, or mental retardation;

2. Shift work, defined as recurring work between 22:00-05:00;

3. A diagnosis of clinically significant obstructive sleep apnea;

4. Serum creatinine > 1.5 mg/dl in men or >1.3 mg/del in women;

5. Significant liver disease (>3x upper limit of normal);

6. Diabetes mellitus;

7. Past diagnosis of gastroesophageal reflux disease,

8. Transmeridian travel across ≥3 time zones in the two weeks before the 48hr deep phenotype sessions;

9. Use of oral or intravenous antibiotics in the 6 months prior to enrollment;

10. Subjects, who have received an experimental drug, used an experimental medical device within 30 days prior to screening, or who gave a blood donation of ≥ one pint within 8 weeks prior to screening;

11. > 2 drinks of alcohol per day;

12. Use of drugs assessed in the urinary drug test;

13. Nursing or pregnant (pregnancy will be repeatedly assessed at the beginning of each of the four inpatient visits, i.e. prior to the start of blood draws);

14. Use of pacemaker or implantable Cardioverter Defibrillator (ICD);

15. Bilateral mastectomy;

16. History of Raynaud's phenomenon;

17. Known allergy against natural latex rubber (contained in ABP bladder and tubing);

18. Subjects taking medication with alpha-blockers.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 75 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

University of Pennsylvania

OTHER

Sponsor Role: lead

Responsible Party

Carsten Skarke, MD

ADJ Research Associate Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Garret A FitzGerald, MD

Role: PRINCIPAL_INVESTIGATOR

University of Pennsylvania

Carsten C Skarke, MD

Role: PRINCIPAL_INVESTIGATOR

University of Pennsylvania

Locations

Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine

Philadelphia, Pennsylvania, United States

Countries

United States

References

Skarke C, Lahens NF, Rhoades SD, Campbell A, Bittinger K, Bailey A, Hoffmann C, Olson RS, Chen L, Yang G, Price TS, Moore JH, Bushman FD, Greene CS, Grant GR, Weljie AM, FitzGerald GA. A Pilot Characterization of the Human Chronobiome. Sci Rep. 2017 Dec 7;7(1):17141. doi: 10.1038/s41598-017-17362-6.

Reference Type: BACKGROUND

PMID: 29215023 (View on PubMed)

Related Links

https://www.inquirer.com/health/chronobiome-body-clock-university-pennsylvania-20190307.html

Philadelphia Inquirer

Other Identifiers

834156

Identifier Type: -

Identifier Source: org_study_id